Extreme lateral interbody fusion (XLIF) in a consecutive series of 72 patients. Biomol Biomed [Internet]. 2021 Oct. 1 [cited 2024 Apr. 28];21(5):587-9. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/5261